Show simple item record DeVore, AD Milano, CA Rogers, JG
dc.coverage.spatial China 2015-12-03T21:38:01Z 2014-11
dc.identifier acs-03-06-603
dc.identifier.citation Ann Cardiothorac Surg, 2014, 3 (6), pp. 603 - 605
dc.identifier.issn 2225-319X
dc.description.abstract The past five years have seen remarkable growth in the use of durable, continuous flow left ventricular assist devices (LVAD) with associated improvements in mortality, quality of life, functionality and end-organ function. To sustain the growth of this important therapy, the LVAD community must now address key issues focused around the costs of LVAD care, refined patient selection, and reducing complications associated with this therapy. In this perspective piece, we discuss many of these issues.
dc.format.extent 603 - 605
dc.language eng
dc.relation.ispartof Ann Cardiothorac Surg
dc.relation.isversionof 10.3978/j.issn.2225-319X.2014.08.22
dc.subject Mechanical support
dc.subject advanced heart failure
dc.subject ventricular assist devices (VAD)
dc.title VAD therapy 20/20: moving beyond the myopic view of a nascent therapy.
dc.type Journal Article
pubs.issue 6
pubs.organisational-group /Duke
pubs.organisational-group /Duke/School of Medicine
pubs.organisational-group /Duke/School of Medicine/Clinical Science Departments
pubs.organisational-group /Duke/School of Medicine/Clinical Science Departments/Medicine
pubs.organisational-group /Duke/School of Medicine/Clinical Science Departments/Medicine/Medicine, Cardiology
pubs.organisational-group /Duke/School of Medicine/Clinical Science Departments/Surgery
pubs.organisational-group /Duke/School of Medicine/Clinical Science Departments/Surgery/Surgery, Cardiovascular and Thoracic Surgery
pubs.organisational-group /Duke/School of Medicine/Institutes and Centers
pubs.organisational-group /Duke/School of Medicine/Institutes and Centers/Duke Clinical Research Institute
pubs.publication-status Published
pubs.volume 3

Files in this item

This item appears in the following Collection(s)

Show simple item record